Bookmark
Forward
Explore Literature Results
Explore Clinical Trials Results
QuickView for AKT2 (gene)
Most Relevant Literature
- MiR-378 Inhibits Angiotensin II-Induced Cardiomyocyte Hypertrophy by Targeting AKT2.
- Lactate accumulation induced by Akt2-PDK1 signaling promotes pulmonary fibrosis.
- Ablation of Akt2 rescues chronic caloric restriction-provoked myocardial remodeling and dysfunction …
- Spontaneous Akt2 deficiency in a colony of NOD mice exhibiting early diabetes.
- Active AKT2 stimulation of SREBP1/SCD1-mediated lipid metabolism boosts hepatosteatosis and cancer.
Most Relevant Clinical Trials
- Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer
- A Trial of Ipatasertib in Combination With Atezolizumab
- Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
- Imatinib Mesylate in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Pe…
- Molecular Pathways Involved in the Pathogenesis and Behavior of Mesenchymal Phosphaturic Tumors Caus…
